In medicine and pharmacology, pioglitazone is a member of the drug class of the thiazolidinediones.
It is being marketed as Actos® by the pharmaceutical companies Takeda and Eli Lilly.
Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.
More on [ Pioglitazone ]

Actos - Pioglitazone HCI. Provides product information, diet plans, physical activity information, and prescribing information.
Actos Consumer Information - FDA - Consumer FAQ in html format with a link to approved labeling in pdf format.
Meta Description: [ Consumer Information Sheet ]
DrugDigest: Pioglitazone ( Actos ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.
| Ongoing Safety Analysis for Avandia (Aug. 2007) | |
| Next Video | |